Maximal daily dose of pancreatic enzyme replacement therapy in infants with cystic fibrosis: A reconsideration

Journal of Cystic Fibrosis

Volumn 12, Issue 6, 2013, Pages 784-785

  Borowitz, Drucy ^a   Gelfond, Daniel ^a   Maguiness, Karen ^b   Heubi, James E ^c   Ramsey, Bonnie ^d  

^a UNIVERSITY AT BUFFALO   (United States)

^b RILEY HOSPITAL FOR CHILDREN   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Cystic fibrosis; Infant nutrition; Pancreatic enzymes; Pancreatic insufficiency

Indexed keywords

FAT; TRIACYLGLYCEROL LIPASE;

ARTICLE; CLINICAL PRACTICE; COLON DISEASE; CYSTIC FIBROSIS; GROWTH, DEVELOPMENT AND AGING; HUMAN; INFANT DISEASE; MALABSORPTION; NEWBORN SCREENING; PANCREAS INSUFFICIENCY; SUBSTITUTION THERAPY; UNITED KINGDOM;

CYSTIC FIBROSIS; INFANT NUTRITION; PANCREATIC ENZYMES; PANCREATIC INSUFFICIENCY;

CYSTIC FIBROSIS; ENZYME REPLACEMENT THERAPY; HUMANS; INFANT; INFANT NUTRITIONAL PHYSIOLOGICAL PHENOMENA; LIPASE;

EID: 84888068385     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2013.05.011     Document Type: Article

References (13)

1. Bronstein M.N., Sokol R.J., Abman S.H., Chatfield B.A., Hammond K.B., Hambidge K.M., et al. Pancreatic insufficiency, growth, and nutrition in infants identified by newborn screening as having cystic fibrosis. J Pediatr 1992, 120:533-540.
2. Walkowiak J., Nousia-Arvanitakis S., Agguridaki C., Fotoulaki M., Strzykala K., Balassopoulou A., et al. Longitudinal follow-up of exocrine pancreatic function in pancreatic sufficient cystic fibrosis patients using the fecal elastase-1 test. J Pediatr Gastroenterol Nutr 2003, 36:474-478.
3. Borowitz D., Baker R.D., Stallings V. Consensus report on nutrition for pediatric patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 2002, 35:246-259.
4. Sinaasappel M., Stern M., Littlewood J., Wolfe S., Stein G. Nutrition in patients with cystic fibrosis: a European Consensus. J Cyst Fibros 2002, 1:51-75.
5. Smyth R.L., van Velzen D., Smyth A.R., Lloyd D.A., Heaf D.P. Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes. Lancet 1994, 343:85-86.
6. FitzSimmons S.C., Burkhart G.A., Borowitz D., Grand R.J., Hammerstrom T., Durie P.R., et al. High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. N Engl J Med 1997, 336:1283-1289.
7. Kalnins D., Durie P.R., Ellis L. Pancreatic enzymes - evaluation of current practice in a large CF clinic. Pediatr Pulmonol 1995, 20(Suppl. 12):266.
8. Leonard, C. Pancreatic Enzyme Replacement Therapy (PERT). Dosage recommendations for cystic fibrosis infants. Nottingham Neonatal Service - Clinical Guideline F5, (Version 1: October 1999) Review Date: May 2005.
9. Committee on Safety of Medicines Report of the Pancreatic Enzymes Working Party, London 1995.
10. Stallings V.A., Stark L.J., Robinson K.A., Feranchak A.P., Quinton H. Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review. J Am Diet Assoc 2008, 108:832-839.
11. Borowitz D., Robinson K.A., Rosenfeld M., Davis S.D., Sabadosa K.A., Spear S.L., et al. Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis. J Pediatr 2009, 155:S73.
12. Cystic Fibrosis Foundation Patient Registry Annual Report to the Center Directors 2010, Cystic Fibrosis Foundation, Bethesda, MD.
13. Cystic Fibrosis Foundation Patient Registry Annual Report to the Center Directors 2011, Cystic Fibrosis Foundation, Bethesda, MD.